MTF Biologics gains better insights into business processes and practices with Board
About MTF Biologics
Headquartered in Edison, New Jersey, MTF Biologics has spent more than 30 years honoring donated gifts by developing innovative, effective allograft solutions to help people heal. From orthopedics to wound care to plastic and reconstructive surgery, we have become a force in scientific progress and patient advocacy.
MTF Biologics, formerly known as The Musculoskeletal Transplant Foundation (MTF), in 2008 saw the need for more robust reporting and better analytical tools for both the technical and business sides of their non-profit organization. As part of this initiative, MTF Biologics began researching business intelligence tools that met the organization’s requirements and could scale for future analytics or planning needs. The team tasked with this project evaluated both Board and IBM’s Cognos solution, and decided to move forward with Board for a variety of reasons.
MTF Biologics chose Board for four of its core offerings and capabilities. As a non-profit organization, MTF Biologics was interested in an affordable, yet robust solution to meet its reporting and analytics challenges and with the scalability to meet future planning needs. With its all-in-one business intelligence and planning capabilities, Board’s total cost of ownership is significantly lower than that of the competition. Additionally, MTF Biologics was looking for a solution that offered both a user-friendly interface and ease-of-use for all users.
“We chose Board because it met our needs of having a robust business intelligence tool that had clear, straightforward approach to presenting critical information,” said Leeza Mathews, Manager IT MIS, MTF Biologics.
With Board’s self-service environment, users can easily search for information, interact intuitively with their data, and perform in-depth analyses with the utmost simplicity. Furthermore, the programming-free approach empowers business users to rapidly develop and maintain sophisticated analytical and planning applications with minimal IT support. Lastly, the team at MTF Biologics was impressed by the graphical and visualization capabilities of Board.
“With Board, we are able leverage its analytic and reporting functionality to effectively monitor performance and make key business decisions,” said Leeza Mathews.
Today, MTF Biologics uses Board for much more than traditional business intelligence. MTF Biologics has an advanced analytics and planning strategy that includes the use of Board for budgeting processes, sales reporting, operations reporting and planning, interactive reporting, trend spotting, and customized reporting and dashboarding. MTF Biologics will continue to leverage Board’s many reporting, analytics and planning capabilities in its formal and evolving organization-wide BI strategy. With Board, MTF Biologics has gained better insight into its business processes, improved reporting on financials and streamlined budget process – and there’s much more to come.